Clinical trial
A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With…
NCT00430235 · British Columbia Cancer Agency, Other · Completed
Key facts
| NCT number | NCT00430235 |
|---|---|
| Title | A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer |
| Official title | A Phase II Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer |
| Lead sponsor | British Columbia Cancer Agency, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Prostate |
| Intervention type | Drug |
| Interventions | BAY 43-9006 |
| Enrollment | 39 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2010 |
| First posted | Feb 1, 2007 |
| Last update posted | Aug 5, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: